$CYCA
CYTTA CORP.

2024 Q2 Form 10-Q Financial Statement

#000147793224003165 Filed on May 20, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $832.00 $0.00 $8.118K
YoY Change -89.75% -100.0% 767.31%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.286M $895.2K $648.4K
YoY Change 1.54% 38.07% -57.14%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $10.02K $10.51K $11.74K
YoY Change -8.15% -10.48% -1.44%
% of Gross Profit
Operating Expenses $1.296M $905.7K $660.1K
YoY Change 1.46% 37.2% -56.71%
Operating Profit -$1.295M -$905.7K -$652.0K
YoY Change 2.04% 38.91% -57.22%
Interest Expense -$158.9K -$82.83K -$11.31K
YoY Change -2138.5% 632.36% 443.75%
% of Operating Profit
Other Income/Expense, Net -$158.9K $82.83K $11.31K
YoY Change -566.61% 632.5% -9.54%
Pretax Income -$1.454M -$988.5K -$663.3K
YoY Change 11.57% 49.03% -56.53%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.454M -$988.5K -$663.3K
YoY Change 11.57% 49.03% -56.53%
Net Earnings / Revenue -174732.81% -8170.87%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 467.2M shares 434.7M shares 383.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.717M $441.7K $214.2K
YoY Change 252.59% 106.21% -89.99%
Cash & Equivalents $1.717M $441.7K $214.2K
Short-Term Investments
Other Short-Term Assets $629.1K $521.2K $118.6K
YoY Change 445.23% 339.39% -71.19%
Inventory $0.00
Prepaid Expenses $629.1K $521.2K $118.6K
Receivables
Other Receivables
Total Short-Term Assets $2.346M $962.9K $332.8K
YoY Change 289.49% 189.32% -86.96%
LONG-TERM ASSETS
Property, Plant & Equipment $61.16K $56.47K $99.35K
YoY Change -30.84% -43.16% -32.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $245.8K $351.1K
YoY Change
Total Long-Term Assets $306.9K $407.6K $99.35K
YoY Change 247.06% 310.26% -32.32%
TOTAL ASSETS
Total Short-Term Assets $2.346M $962.9K $332.8K
Total Long-Term Assets $306.9K $407.6K $99.35K
Total Assets $2.653M $1.370M $432.2K
YoY Change 284.06% 217.12% -83.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.155M $1.204M $543.5K
YoY Change 1.75% 121.57% 299.85%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $43.20K $43.20K $40.00K
YoY Change 8.0% 8.0%
Long-Term Debt Due $60.00K
YoY Change
Total Short-Term Liabilities $2.548M $3.036M $695.6K
YoY Change 39.27% 336.45% 150.01%
LONG-TERM LIABILITIES
Long-Term Debt $1.312M $1.755M $19.71K
YoY Change 3578.63% 8804.11%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.312M $1.755M $19.71K
YoY Change 3578.63% 8804.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.548M $3.036M $695.6K
Total Long-Term Liabilities $1.312M $1.755M $19.71K
Total Liabilities $2.548M $3.036M $715.3K
YoY Change 36.61% 324.43% 157.09%
SHAREHOLDERS EQUITY
Retained Earnings -$36.10M -$34.65M -$29.64M
YoY Change 16.69% 16.91% 16.39%
Common Stock $467.3K $441.9K $392.8K
YoY Change 15.93% 12.51% 4.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $105.2K -$1.665M -$283.1K
YoY Change
Total Liabilities & Shareholders Equity $2.653M $1.370M $432.2K
YoY Change 284.06% 217.12% -83.99%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$1.454M -$988.5K -$663.3K
YoY Change 11.57% 49.03% -56.53%
Depreciation, Depletion And Amortization $10.02K $10.51K $11.74K
YoY Change -8.15% -10.48% -1.44%
Cash From Operating Activities -$620.7K -$466.1K -$229.2K
YoY Change 123.95% 103.4% -51.64%
INVESTING ACTIVITIES
Capital Expenditures $14.71K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$14.71K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.911M 517.5K 300.0K
YoY Change 247.45% 72.5%
NET CHANGE
Cash From Operating Activities -620.7K -466.1K -229.2K
Cash From Investing Activities -14.71K
Cash From Financing Activities 1.911M 517.5K 300.0K
Net Change In Cash 1.276M 51.40K 70.84K
YoY Change 367.5% -27.44% -114.95%
FREE CASH FLOW
Cash From Operating Activities -$620.7K -$466.1K -$229.2K
Capital Expenditures $14.71K
Free Cash Flow -$635.4K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Profit Loss
ProfitLoss
1764019 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-65436 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
85726 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
225616 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001383088
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Security12g Title
Security12gTitle
Common Stock, $0.001 par value
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
441946581 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-257458
dei Entity Registrant Name
EntityRegistrantName
CYTTA CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0505761
dei Entity Address Address Line1
EntityAddressAddressLine1
5450 W Sahara Ave Suite 300A
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89146
dei City Area Code
CityAreaCode
702
dei Local Phone Number
LocalPhoneNumber
900-7022
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
467232385 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
441946581 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
426831170 shares
CY2024Q1 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Revenues
Revenues
8118 usd
us-gaap Revenues
Revenues
2411 usd
us-gaap Revenues
Revenues
13824 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
216834 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
430042 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
403484 usd
CY2024Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
688876 usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
434505 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1466120 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1363080 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
905710 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
660121 usd
us-gaap Operating Expenses
OperatingExpenses
1896162 usd
us-gaap Operating Expenses
OperatingExpenses
1766564 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-905710 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-652003 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1893751 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1752740 usd
CY2024Q1 us-gaap Interest Expense Other
InterestExpenseOther
82954 usd
CY2023Q1 us-gaap Interest Expense Other
InterestExpenseOther
11308 usd
us-gaap Interest Expense Other
InterestExpenseOther
154241 usd
us-gaap Interest Expense Other
InterestExpenseOther
11334 usd
CY2024Q1 us-gaap Interest Income Other
InterestIncomeOther
123 usd
CY2023Q1 us-gaap Interest Income Other
InterestIncomeOther
0 usd
us-gaap Interest Income Other
InterestIncomeOther
323 usd
us-gaap Interest Income Other
InterestIncomeOther
55 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
82831 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11308 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
153918 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11279 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-988541 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-663311 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2047669 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1764019 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-988541 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-663311 usd
us-gaap Net Income Loss
NetIncomeLoss
-2047669 usd
us-gaap Net Income Loss
NetIncomeLoss
-1764019 usd
CY2024Q1 cyca Basic And Diluted Earnings Per Share Basic And Diluted
BasicAndDilutedEarningsPerShareBasicAndDiluted
-0.00
CY2023Q1 cyca Basic And Diluted Earnings Per Share Basic And Diluted
BasicAndDilutedEarningsPerShareBasicAndDiluted
-0.00
cyca Basic And Diluted Earnings Per Share Basic And Diluted
BasicAndDilutedEarningsPerShareBasicAndDiluted
-0.00
cyca Basic And Diluted Earnings Per Share Basic And Diluted
BasicAndDilutedEarningsPerShareBasicAndDiluted
-0.00
CY2024Q1 cyca Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
440663814 shares
CY2023Q1 cyca Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
386784983 shares
cyca Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
434586858 shares
cyca Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
383800112 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-260359 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
169200 usd
CY2023Q4 cyca Common Stock Issued For Accounts Payable And Accrued Liabilities Amount
CommonStockIssuedForAccountsPayableAndAccruedLiabilitiesAmount
50781 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-1059128 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1099506 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
104000 usd
CY2024Q1 cyca Common Stock Issued For Accounts Payable And Accrued Liabilities Amount
CommonStockIssuedForAccountsPayableAndAccruedLiabilitiesAmount
46336 usd
CY2024Q1 cyca Warrants Vested To Purchase Common Stock
WarrantsVestedToPurchaseCommonStock
272299 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-988541 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1665412 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
461792 usd
CY2022Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
407275 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-1100708 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-231641 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
275300 usd
CY2023Q1 cyca Common Stock Issued For Accounts Payable Amount
CommonStockIssuedForAccountsPayableAmount
39375 usd
CY2023Q1 cyca Common Stock Issued For Common Stock Payable Amount
CommonStockIssuedForCommonStockPayableAmount
54750 usd
CY2023Q1 cyca Common Stock Issued For Accrued Liabilities Related Party Amount
CommonStockIssuedForAccruedLiabilitiesRelatedPartyAmount
55393 usd
CY2023Q1 cyca Common Stock And Warrants Issued For Cash Amount
CommonStockAndWarrantsIssuedForCashAmount
100000 usd
CY2023Q1 cyca Warrants Issued In Conjunction With Notes Payable
WarrantsIssuedInConjunctionWithNotesPayable
87001 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-663311 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-283133 usd
us-gaap Profit Loss
ProfitLoss
2047669 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-992042 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-929607 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
30706 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6707 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
4834 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Depreciation
Depreciation
21084 usd
us-gaap Depreciation
Depreciation
23642 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
126946 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-78985 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
28040 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
109189 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2411 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
18646 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-790660 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-840939 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
100000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
40000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
557500 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
160000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
557500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
300000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-233160 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-540939 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
674824 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
755122 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
441664 usd
CY2024Q1 cyca Stock Based Compensation
StockBasedCompensation
104000 usd
CY2024Q1 cyca Amortization Of Stock Based Compensation
AmortizationOfStockBasedCompensation
-715004 usd
CY2023Q1 cyca Amortization Of Stock Based Compensation
AmortizationOfStockBasedCompensation
0 usd
CY2024Q1 cyca Prepaid Expense From Other Activity
PrepaidExpenseFromOtherActivity
-65435 usd
CY2023Q1 cyca Prepaid Expense From Other Activity
PrepaidExpenseFromOtherActivity
85725 usd
CY2024Q1 cyca Prepaid Expenses Ending Balance
PrepaidExpensesEndingBalance
872313 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
214183 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
cyca Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
273200 usd
cyca Issuance Of Common Stock For Services
IssuanceOfCommonStockForServices
682575 usd
cyca Common Stock Issued For Accounts Payable And Accrued Liabilities
CommonStockIssuedForAccountsPayableAndAccruedLiabilities
101949 usd
cyca Common Stock Issued For Accounts Payable And Accrued Liabilities
CommonStockIssuedForAccountsPayableAndAccruedLiabilities
30000 usd
cyca Common Stock Issued For Accrued Expenses Related Party
CommonStockIssuedForAccruedExpensesRelatedParty
0 usd
cyca Common Stock Issued For Accrued Expenses Related Party
CommonStockIssuedForAccruedExpensesRelatedParty
55393 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34651149 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.</p>
CY2024Q1 cyca Prepaid Expenses Beginning Balance
PrepaidExpensesBeginningBalance
1548752 usd
CY2023Q1 cyca Prepaid Expenses Beginning Balance
PrepaidExpensesBeginningBalance
32897 usd
CY2023Q1 cyca Prepaid Expenses Ending Balance
PrepaidExpensesEndingBalance
118622 usd
CY2024Q1 cyca Prepaid Expense Portion Noncurrent
PrepaidExpensePortionNoncurrent
351109 usd
CY2023Q1 cyca Prepaid Expense Portion Noncurrent
PrepaidExpensePortionNoncurrent
0 usd
CY2024Q1 cyca Prepaid Expense Portion Current
PrepaidExpensePortionCurrent
521204 usd
CY2023Q1 cyca Prepaid Expense Portion Current
PrepaidExpensePortionCurrent
118622 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.</p>
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
230900 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
230900 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
174426 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
153342 usd
CY2024Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
56474 usd
CY2023Q3 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
77558 usd
CY2024Q1 us-gaap Depreciation
Depreciation
10508 usd
us-gaap Depreciation
Depreciation
21084 usd
CY2023Q1 us-gaap Depreciation
Depreciation
11738 usd
us-gaap Depreciation
Depreciation
23642 usd
CY2024Q1 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
216834 usd
CY2023Q1 us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
225616 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
430042 usd
us-gaap Costs And Expenses Related Party
CostsAndExpensesRelatedParty
403484 usd
CY2023Q1 us-gaap Shares Issued
SharesIssued
3000000 shares
CY2024Q1 cyca Monthly Fee Increased Per Month
MonthlyFeeIncreasedPerMonth
15000 usd
us-gaap Other Expenses
OtherExpenses
22525 usd
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
250000 shares
CY2020Q4 cyca Annual Lease Payment Related Party
AnnualLeasePaymentRelatedParty
50000 usd
CY2024Q1 cyca Accounts Payable Related Parties Transaction
AccountsPayableRelatedPartiesTransaction
680061 usd
CY2023Q3 cyca Accounts Payable Related Parties Transaction
AccountsPayableRelatedPartiesTransaction
772532 usd
CY2024Q1 cyca Accounts Payables Related Parties Current
AccountsPayablesRelatedPartiesCurrent
680061 usd
CY2023Q3 cyca Accounts Payables Related Parties Current
AccountsPayablesRelatedPartiesCurrent
772532 usd
CY2023Q1 cyca Promissory Note Face Value
PromissoryNoteFaceValue
40000 usd
CY2023Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
1000000 usd
CY2023Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-01-10
CY2024Q1 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
43200 usd
CY2023Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.08 pure
CY2023Q1 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
1.00
CY2023Q1 us-gaap Class Of Warrant Or Right Unissued
ClassOfWarrantOrRightUnissued
2000000 shares
CY2023Q1 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
1.00
CY2024Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1754995 usd
CY2023Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1166788 usd
CY2024Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.001
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
441946581 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
426831170 shares
cyca Common Stock Issued For Services Shares
CommonStockIssuedForServicesShares
7750000 shares
CY2023Q1 cyca Common Stock Issued For Services Shares
CommonStockIssuedForServicesShares
3825000 shares
cyca Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
682575 usd
CY2023Q1 cyca Common Stock Issued For Services Amount
CommonStockIssuedForServicesAmount
275300 usd
cyca Common Stock Issued For Payment Of Account Payable Share
CommonStockIssuedForPaymentOfAccountPayableShare
750000 shares
cyca Common Stock Issued For Payment Of Account Payable
CommonStockIssuedForPaymentOfAccountPayable
39375 usd
cyca Stock Based Consulting Expense
StockBasedConsultingExpense
9375 usd
cyca Commonstock Issued Settlement Of Stock Payable
CommonstockIssuedSettlementOfStockPayable
54750 usd
cyca Issuance Of Common Stock Exchange For Consulting Services
IssuanceOfCommonStockExchangeForConsultingServices
500000 shares
cyca Issuance Of Common Stock Exchange For Consulting Services Per Shares Market Price
IssuanceOfCommonStockExchangeForConsultingServicesPerSharesMarketPrice
0.11076
cyca Issuance Of Common Stock Exchange For Consulting Services Fair Value
IssuanceOfCommonStockExchangeForConsultingServicesFairValue
55393 usd
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
3000000 shares
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
21500 usd
us-gaap Share Based Compensation
ShareBasedCompensation
39375 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
624458 usd
CY2023Q1 cyca Purchase Of Warrant Common Stock Value
PurchaseOfWarrantCommonStockValue
449651 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6000000 shares
cyca Operating Income Losses
OperatingIncomeLosses
2194907 usd
cyca Operating Income Losses
OperatingIncomeLosses
1973226 usd
cyca Less Valuation Allowance
LessValuationAllowance
-2194907 usd
cyca Less Valuation Allowance
LessValuationAllowance
-1973226 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
10451000 usd
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
9396000 usd
CY2024Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
0 usd
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
2411 usd
CY2023Q1 us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
8118 usd
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
13824 usd
CY2024Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
9059 usd

Files In Submission

Name View Source Status
0001477932-24-003165-index-headers.html Edgar Link pending
0001477932-24-003165-index.html Edgar Link pending
0001477932-24-003165.txt Edgar Link pending
0001477932-24-003165-xbrl.zip Edgar Link pending
cyca-20240331.xsd Edgar Link pending
cyca_10q.htm Edgar Link pending
cyca_ex311.htm Edgar Link pending
cyca_ex312.htm Edgar Link pending
cyca_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
cyca-20240331_def.xml Edgar Link unprocessable
cyca-20240331_lab.xml Edgar Link unprocessable
cyca-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cyca_10q_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cyca-20240331_cal.xml Edgar Link unprocessable